• Bismuth Subsalicylate: Advanced Protocols for GI Research

  2026-05-26

  Bismuth Subsalicylate (1,3,2λ2-benzodioxabismin-4-one) enables robust, reproducible workflows in gastrointestinal disorder research by uniquely targeting prostaglandin pathways and providing reliable performance in both inflammation and apoptosis models. This guide translates the latest reference innovations and APExBIO’s product strengths into actionable protocol enhancements and troubleshooting strategies.

• Scenario-Driven Best Practices with HOBt (1-Hydroxybenzotria

  2026-05-26

  This article addresses common laboratory challenges in peptide synthesis and amide bond formation, providing evidence-based strategies for minimizing epimerization and maximizing reproducibility. Learn how HOBt (1-Hydroxybenzotriazole) (SKU A7025) from APExBIO delivers high-purity, workflow-compatible solutions tailored for biomedical research assays.

• Targeting Senescent Tumor Cells with BH3 Mimetics in TP53 Wi

  2026-05-26

  This study demonstrates that BH3 mimetic drugs, by selectively inducing apoptosis in chemotherapy-induced senescent breast cancer cells with functional TP53, can enhance tumor regression and survival. The findings provide a mechanistic rationale for targeting BCL-XL/BCL-XL–MCL1 survival pathways to overcome resistance associated with tumor cell senescence.

• Tiamulin (Thiamutilin): Metabolism, PK/PD, and Assay Precisi

  2026-05-25

  Explore the advanced metabolic profiling and pharmacokinetics of Tiamulin (Thiamutilin), a pleuromutilin antibiotic for veterinary use. This article uniquely focuses on interspecies metabolism, assay optimization, and practical insights for precise experimental design.

• Nutlin-3a as an MDM2 Inhibitor: Enhanced Protocols for Cance

  2026-05-24

  Nutlin-3a enables precise, reproducible activation of the p53 pathway in cancer cell models, facilitating robust studies of cell cycle arrest and apoptosis induction. By integrating workflow optimizations and troubleshooting tips, researchers can address common assay challenges and leverage advanced insights from the latest glioblastoma research.

• Pyridostatin TFA in G-Quadruplex and TDP-43 Research Workflo

  2026-05-23

  Pyridostatin TFA, a robust G-quadruplex DNA structure stabilizer, is transforming experimental approaches in telomere biology, cancer, and neurodegenerative disease research. This guide distills advanced protocols, troubleshooting strategies, and key innovations to help research teams maximize reproducibility and insight when deploying Pyridostatin in cellular and molecular models.

• Decoding Colonic Barrier Failure: DSS Models and Repair Circ

  2026-05-22

  Explore how Dextran sulfate sodium salt (MW 35000-45000) empowers translational researchers to dissect epithelial damage and repair in ulcerative colitis. This thought-leadership article bridges mechanistic insights—such as GPR35-KLF5 metabolic gatekeeping—with actionable guidance for optimizing DSS mouse models, advancing both assay performance and clinical relevance.

• 7ACC2 and Immunometabolic Control: A New Era in Tumor Microe

  2026-05-22

  Discover how 7ACC2, a potent monocarboxylate transporter 1 inhibitor, advances cancer metabolism research by targeting both lactate and pyruvate transport. This article uniquely connects MCT1 inhibition to immunometabolic reprogramming of the tumor microenvironment.

• Elobixibat Hydrate: Selective IBAT Inhibitor for Constipatio

  2026-05-21

  Elobixibat hydrate is a highly selective inhibitor of the ileal bile acid transporter (IBAT), offering targeted modulation of bile acid reabsorption and enterohepatic circulation. Clinically, it is used for the treatment of chronic idiopathic constipation and metabolic disturbances in type 2 diabetes mellitus. Its low systemic bioavailability and robust safety profile make it an evidence-backed option for both research and therapeutic contexts.

• Talabostat Mesylate: Precision FAP Inhibition and Immune Mod

  2026-05-21

  Explore how Talabostat mesylate (PT-100) enables targeted FAP and DPP4 inhibition to modulate the tumor microenvironment and enhance immune responses. This in-depth analysis reveals new assay considerations and connects recent advances in skin barrier biology to cancer research.

• Trichostatin A (TSA): Epigenetic Modulation and Immune Insig

  2026-05-20

  Explore the multifaceted role of Trichostatin A (TSA) in epigenetic cancer research and immune modulation. This article delivers advanced mechanistic insights, unique reference-backed findings, and protocol guidance for maximizing TSA’s experimental value.

• NMDA (N-Methyl-D-aspartic acid): Precision in Excitotoxicity

  2026-05-20

  NMDA (N-Methyl-D-aspartic acid) enables reproducible modeling of excitotoxicity and oxidative stress, especially in neurodegenerative and retinal disease research. This article outlines actionable workflows, troubleshooting insights, and practical enhancements using APExBIO’s NMDA to elevate laboratory outcomes.

• DPP9 Mutation Drives Infantile Autoinflammation via Inflamma

  2026-05-19

  A recent study describes how a de novo DPP9 mutation disrupts negative regulation of NLRP1 and CARD8 inflammasomes, leading to severe infancy-onset, hemophagocytic lymphohistiocytosis–like hyperinflammation. These findings advance our understanding of dipeptidyl peptidase–mediated immune restraint and offer new avenues for dissecting inflammasome-related immunopathology.

• NLRP10 Regulates Keratinocyte Survival and Differentiation i

  2026-05-19

  This study elucidates the role of NLRP10 in maintaining epidermal homeostasis by promoting keratinocyte survival and P63-dependent differentiation, revealing its downregulation in atopic dermatitis (AD) skin. The findings highlight NLRP10 as a promising molecular target for restoring skin barrier function in AD patients.

• KR-12 Human Antimicrobial Peptide: Workflow, Optimization, a

  2026-05-18

  KR-12, the minimal human LL-37 fragment, is a precision tool for antimicrobial, anti-biofilm, and immunomodulatory research. This guide delivers actionable protocols, troubleshooting, and the latest evidence for maximizing KR-12’s translational value across infection and inflammation models.

454 records 17/31 page Previous Next First page 上5页 1617181920 下5页 Last page